Galapagos NV
GLPG
#5036
Rank
NZ$3.31 B
Marketcap
NZ$49.30
Share price
0.00%
Change (1 day)
-14.52%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2026 (TTM): NZ-$0.93

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is NZ-$0.72. In 2025 the company made an earnings per share (EPS) of NZ$10.17 an increase over its 2024 EPS that were of NZ$2.07.

EPS history for Galapagos NV from 2004 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$0.93-109.11%
2025NZ$10.17390.86%
2024NZ$2.07-67.16%
2023NZ$6.31-199.64%
2022NZ-$6.3399.03%
2021NZ-$3.18-68.98%
2020NZ-$10.26-298.06%
2019NZ$5.18-554.64%
2018NZ-$1.14-77.18%
2017NZ-$4.99-326.21%
2016NZ$2.21-134.19%
2015NZ-$6.45-371.34%
2014NZ$2.38-445.98%
2013NZ-$0.6932.88%
2012NZ-$0.52-82.07%
2011NZ-$2.89-817.9%
2010NZ$0.4012.73%
2009NZ$0.36-120.79%
2008NZ-$1.72-37.67%
2007NZ-$2.7539.64%
2006NZ-$1.9728.17%
2005NZ-$1.546.25%
2004NZ-$1.45

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.53-2,243.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$5.54-865.44%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$6.35-976.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.38-567.13%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$2.25-410.66%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$11.88-1,739.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$5.69-884.96%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
NZ$7.09-1,079.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$1.12-254.65%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel